LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AI Combined with Genomic Surveillance Beats Humans at Detecting Infectious Disease Outbreaks in Hospital Settings

By LabMedica International staff writers
Posted on 23 Nov 2021
Print article
Image: Dr. Lee Harrison and Alex Sundermann load samples for genomic sequencing (Photo courtesy of Nathan Langer/UPMC)
Image: Dr. Lee Harrison and Alex Sundermann load samples for genomic sequencing (Photo courtesy of Nathan Langer/UPMC)

By coupling machine learning with whole genome sequencing, scientists have greatly improved the quick detection of infectious disease outbreaks within a hospital setting over traditional methods for tracking outbreaks.

The process developed by scientists at the University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) and Carnegie Mellon University (Pittsburgh, PA, USA) indicates a way for health systems to identify and then stop hospital-based infectious disease outbreaks in their tracks, cutting costs and saving lives. The Enhanced Detection System for Healthcare-Associated Transmission (EDS-HAT) couples the recent development of affordable genomic sequencing with computer algorithms connected to the vast trove of data in electronic health records. When the sequencing detects that any two or more patients in a hospital have near-identical strains of an infection, machine learning quickly mines those patients’ electronic health records for commonalities – whether that be close proximity of hospital beds, a procedure using the same equipment or a shared health care provider – alerting infection preventionists to investigate and halt further transmission.

Ordinarily, this process requires clinicians to notice that two or more patients have a similar infection and alert their infection prevention team, which can then review patient records to attempt to find how the infection was transmitted. From November 2016 to November 2018, UPMC Presbyterian Hospital ran EDS-HAT with a six-month lag for a few select infectious pathogens often associated with health care-acquired infections nationwide, while continuing with real-time, traditional infection prevention methods. The team then investigated how well EDS-HAT performed. EDS-HAT detected 99 clusters of similar infections in that two-year period and identified at least one potential transmission route in 65.7% of those clusters. During the same period, infection prevention used whole genome sequencing to aid in the investigation of 15 suspected outbreaks, two of which revealed genetically related infections. If EDS-HAT had been running in real-time, the team estimates as many as 63 transmissions of an infectious disease from one patient to another could have been prevented. It also would have saved the hospital as much as USD 692,500.

In one case-study, EDS-HAT found an outbreak of vancomycin-resistant Enterococcus faecium that it traced to an interventional radiology procedure involving injection of sterile contrast that was being performed according to manufacturer instructions. Due to EDS-HAT detecting the outbreak, UPMC alerted the manufacturer to the instructions that led to faulty sterilization practices. UPMC plans to introduce EDS-HAT in real-time at UPMC Presbyterian Hospital and expects this innovation to benefit other infection prevention and control programs in the future. And the original EDS-HAT, which primarily focused on drug-resistant bacterial pathogens, will soon be expanding to incorporate sequencing of respiratory viruses, including COVID-19.

“The current method used by hospitals to find and stop infectious disease transmission among patients is antiquated. These practices haven’t changed significantly in over a century,” said senior author Lee Harrison, M.D., professor of infectious diseases at Pitt’s School of Medicine and epidemiology at Pitt’s Graduate School of Public Health. “Our process detects important outbreaks that would otherwise fly under the radar of traditional infection prevention monitoring.”

Related Links:
University of Pittsburgh School of Medicine 
Carnegie Mellon University 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.